Amplify YieldShares Oil Hedged MLP Income ETF(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMLX Amplify YieldShares Oil Hedged MLP Income ETF

盘前交易 12-23 04:11:57 EST

4.05

+0.09

+2.27%

最高4.17	最低3.97	成交量55.09万
今开3.98	昨收3.96	日振幅5.18%
总市值2.76亿	流通市值1.70亿	总股本6,808万
成交额223.80万	换手率1.31%	流通股本4,194万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amplify YieldShares Oil Hedged MLP Income ETF","latestPrice":4.05,"timestamp":1734728400000,"preClose":3.96,"halted":0,"volume":550924,"delay":0,"floatShares":41936322,"shares":68082468,"eps":-3.825343,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.09,"latestTime":"12-23 04:11:57 EST","open":3.98,"high":4.17,"low":3.965,"amount":2237973.224155,"amplitude":0.051768,"askPrice":4.77,"askSize":100,"bidPrice":2.32,"bidSize":100,"shortable":3,"etf":1,"ttmEps":-3.825343,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1641531600000,"adjPreClose":4.05,"adrRate":0,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":4.06,"preClose":4.05,"latestTime":"19:18 EST","volume":34544,"amount":139917.5939,"timestamp":1734740335463},"volumeRatio":0.5565142974260695,"impliedVol":1.5721,"impliedVolPercentile":0.736},"requestUrl":"/m/hq/s/AMLX/wiki","defaultTab":"wiki","newsList":[{"id":"2488944791","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488944791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488944791?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:16","pubTimestamp":1733238980,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时16分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.02%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231620a269acce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231620a269acce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2486002790","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486002790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486002790?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:11","pubTimestamp":1732633860,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时11分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623110098e44b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623110098e44b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2486308028","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.31%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486308028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486308028?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545224,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.31%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为87.20%、61.57%、38.68%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2484326676","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨15.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484326676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484326676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940389,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨15.13%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为517.53%、210.81%、189.81%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为50.92%、35.15%、34.31%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330995be488b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330995be488b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2483802205","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802205?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:30","pubTimestamp":1731594656,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时30分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.37%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223056971a68b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223056971a68b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2483598568","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483598568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483598568?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:17","pubTimestamp":1731525429,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时17分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.29%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为549.55%、486.87%、153.44%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为132.00%、86.83%、73.71%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114031709abbe6aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114031709abbe6aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2482684607","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482684607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482684607?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:40","pubTimestamp":1731357650,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时40分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204405098e41e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204405098e41e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2482364437","title":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village","url":"https://stock-news.laohu8.com/highlight/detail?id=2482364437","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482364437?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:57","pubTimestamp":1731095879,"startTime":"0","endTime":"0","summary":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village路透11月8日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Bath & Body Works、Datadog 和 Savers Value Village。要点 * Bath & Body Works Inc BBWI.N：巴克莱将其股票评级从等权下调至减持 * Datadog Inc DDOG.O：Monness Crespi Hardt将其评级从中性上调至买入  * Montrose Environmental Group Inc MEG.N：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Savers Value Village Inc SVV.N：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMH","BK4094","APA","BK4116","BK4157","AIZ","ACVA","ALRM","BK4023","ACLX","AORT","APP","ASLE","BK4528","IE00B66KJ199.SGD","IE00B894F039.SGD","ACRE","APD","ACIW","AMRC","APPN","AWR","AMPL","AEE","SVV","ARHS","AFRM","BK4196","AGL","ATEN","APLE","GOLF","IE00B7SZL793.SGD","ABNB","ALLO","AMN","ARLO","ADMA","AKAM","ACMR","ARQT","ASTH","LU0240878834.USD","ANET","AKA","DDOG","ARRY","AMLX","ACHR","ALB"],"gpt_icon":1},{"id":"2481100850","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481100850?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.01%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224539abae44e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224539abae44e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2480887926","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887926?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:25","pubTimestamp":1730471139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时25分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2478648441","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648441?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:22","pubTimestamp":1730125328,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2478959164","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478959164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478959164?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:49","pubTimestamp":1729874969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时49分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为834.34%、759.26%、287.94%，振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.，振幅分别为102.56%、91.58%、89.80%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2477489538","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨9.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477489538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477489538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690277,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速上涨9.30%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2477863731","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报5.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863731?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517684,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Biovie Inc.、Werewolf Therapeutics, Inc.、Genprex, Inc.涨幅较大，Genprex, Inc.、Biovie Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为635.20%、372.16%、219.40%，振幅较大的相关个股有Biovie Inc.、Celularity Inc C/Wts 16/07/2026 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为44.26%、39.86%、35.04%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2476102444","title":"BUZZ-遗传性疾病药物试验数据良好，Amylyx 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2476102444","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476102444?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:48","pubTimestamp":1729183682,"startTime":"0","endTime":"0","summary":"** 然而，由于在一项晚期试验中未能延缓疾病的进展，该公司于 3 月份从这两个市场撤出了该药物  ** 包括当期亏损在内，该公司股价年累计下跌了 71%，主要原因是该公司撤出了 Relyvrio。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2475075686","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475075686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475075686?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:48","pubTimestamp":1729000090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时48分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2474470275","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474470275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474470275?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:03","pubTimestamp":1728403398,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时03分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Bio-Path Holdings, Inc.、Portage Biotech Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2440.48%、2313.14%、250.19%，振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena, Inc.、Bio-Path Holdings, Inc.，振幅分别为46.27%、42.80%、39.93%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2473961012","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.07%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473961012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473961012?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:52","pubTimestamp":1728057126,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时52分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2468621680","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468621680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468621680?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:01","pubTimestamp":1726840871,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时01分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2460873658","title":"Amylyx Pharmaceuticals, Inc.2024财年第二财季实现净利润-72.70百万美元，同比减少429.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460873658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460873658?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910643,"startTime":"0","endTime":"0","summary":"8月18日，Amylyx Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-72.70百万美元，同比减少429.41%；其中营业收入为-1.02百万美元，同比减少101.04%，每股基本收益为-1.07美元。从资产负债表来看，Amylyx Pharmaceuticals, Inc.总负债70.85百万美元，其中短期债务2.37百万美元，资产负债比为0.05，流动比率为0.05。机构评级：截至2024年8月18日，当前有6家机构对Amylyx Pharmaceuticals, Inc.目标价做出预测，其中目标均价为4.25美元，其中最低目标价为3.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006269f340746&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006269f340746&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.2256},{"period":"3month","weight":0.3065},{"period":"6month","weight":1.2753},{"period":"1year","weight":-0.7097},{"period":"ytd","weight":-0.7249}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法，通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化，他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法，这意味着它可以单独使用或与其他疗法结合使用，以改变广泛的神经退行性疾病的治疗模式。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.07379},{"month":2,"riseRate":0.666667,"avgChangeRate":0.161981},{"month":3,"riseRate":0,"avgChangeRate":-0.538713},{"month":4,"riseRate":0,"avgChangeRate":-0.231442},{"month":5,"riseRate":0,"avgChangeRate":-0.064193},{"month":6,"riseRate":0.666667,"avgChangeRate":0.381588},{"month":7,"riseRate":1,"avgChangeRate":0.190906},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.022589},{"month":9,"riseRate":0.666667,"avgChangeRate":0.141337},{"month":10,"riseRate":0.666667,"avgChangeRate":0.274859},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.010067},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.088804}],"exchange":"NASDAQ","name":"Amplify YieldShares Oil Hedged MLP Income ETF","nameEN":"Amplify YieldShares Oil Hedged MLP Income ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amplify YieldShares Oil Hedged MLP Income ETF(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amplify YieldShares Oil Hedged MLP Income ETF(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amplify YieldShares Oil Hedged MLP Income ETF,AMLX,Amplify YieldShares Oil Hedged MLP Income ETF股票,Amplify YieldShares Oil Hedged MLP Income ETF股票老虎,Amplify YieldShares Oil Hedged MLP Income ETF股票老虎国际,Amplify YieldShares Oil Hedged MLP Income ETF行情,Amplify YieldShares Oil Hedged MLP Income ETF股票行情,Amplify YieldShares Oil Hedged MLP Income ETF股价,Amplify YieldShares Oil Hedged MLP Income ETF股市,Amplify YieldShares Oil Hedged MLP Income ETF股票价格,Amplify YieldShares Oil Hedged MLP Income ETF股票交易,Amplify YieldShares Oil Hedged MLP Income ETF股票购买,Amplify YieldShares Oil Hedged MLP Income ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amplify YieldShares Oil Hedged MLP Income ETF(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amplify YieldShares Oil Hedged MLP Income ETF(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}